CMT 167 Cell Line
Cancer ToolsHighly metastatic murine alveolar lung carcinoma cell line, derived from the CMT 64 line, that is widely used to investigate metastasis, immune responses, and immunoresistance.
CancerTools.org is a unique non-profit, cancer focused research tools supplier and biorepository. For over 40 years, scientists from academic institutions and leading cancer centres have deposited their research tools with us — and as part of Cancer Research UK, we are determined to accelerate cancer discoveries worldwide. Our diverse cancer portfolio includes innovative tools ranging from antibodies, cell lines, and organoids, to small molecules, PDX models, and other state-of- the-art technologies. We provide exemplary support to academic and industry partners worldwide, offering end-to-end services — from in-bound shipping, storage, and production to authentication and global distribution — ensuring cancer research tools reach the scientific community reliably and efficiently. Such collaborative effort has created one of the most diverse collections of cancer research tools at global scale, backed by best-in-class services to empower scientists, academic spinouts, emerging biotech, and pharma teams alike. How we support your research We help you access leading cancer research tools. Peer-validated tools from top academic labs, not found through traditional vendors. We support you in maximising your research impact. Tools designed for translational relevance and robust scientific outcomes. We can simplify your licensing pathway. One agreement gives you access to tools from global academic institutions, with no delays and no red tape. We help you accelerate and reinvest in cancer research. Every purchase supports our non-profit mission to accelerate progress in cancer research worldwide. Deposit your tools, join a global community, accelerate cancer research.
Highly metastatic murine alveolar lung carcinoma cell line, derived from the CMT 64 line, that is widely used to investigate metastasis, immune responses, and immunoresistance.
Plasmax™ is a physiologically relevant cell culture medium which closely mimics the nutritional & metabolic profile of human plasma, containing over 80 optimised components.
Syngeneic urothelial carcinoma model for bladder cancer research and immunotherapy development
KCGS is a comprehensive collection of 295 highly selective kinase inhibitors targeting 262 human kinases
Syngeneic pancreatic ductal adenocarcinoma (PDA) cell line from the KPC mouse model for immune-competent studies in drug discovery, biomarker development, genetic research, and metastasis